Ensifentrine

Ensifentrine Uses, Dosage, Side Effects, Food Interaction and all others data.

Ensifentrine is under investigation in clinical trial NCT04535986 (A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD).

Trade Name Ensifentrine
Generic Ensifentrine
Ensifentrine Other Names Ensifentrine
Type
Formula C26H31N5O4
Weight Average: 477.565
Monoisotopic: 477.237604498
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Ensifentrine
Ensifentrine

How Ensifentrine works

Ensifentrine is a dual inhibitor of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4); it is also an activator of the cystic fibrosis transmembrane conductance regulator (CFTR). This drug has bronchodilatory and anti-inflammatory properties due to the dual inhibition; it also has mucous viscosity reduction and improved mucociliary clearance effects due to the CFTR activation. Ensifentrine is currently being investigated against COPD, cystic fibrosis, asthma, other respiratory diseases, and COVID-19.

Innovators Monograph

You find simplified version here Ensifentrine

*** Taking medicines without doctor's advice can cause long-term problems.
Share